• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    7.09 Up 0.28(4.11%) Dec 26, 4:00PM EST
    |After Hours : 7.09 0.00 (0.00%) Dec 26, 7:20PM EST
    Add to Portfolio
    Prev Close:6.81
    Open:6.86
    Bid:N/A
    Ask:8.27 x 1000
    1y Target Est:7.81
    Beta:0.86
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:6.85 - 7.09
    52wk Range:4.90 - 9.83
    Volume:3,374,580
    Avg Vol (3m):6,917,770
    Market Cap:1.33B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 4.11%1.33B
    NVSUp 0.20%227.60B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):27.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.05
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback